Cargando…
Mutant allele knockout with novel CRISPR nuclease promotes myelopoiesis in ELANE neutropenia
Severe congenital neutropenia (SCN) is a life-threatening marrow failure disorder, usually caused by heterozygous mutations in ELANE. Potential genetic treatment strategies include biallelic knockout or gene correction via homology-directed repair (HDR). Such strategies, however, involve the potenti...
Autores principales: | Sabo, Peter, Makaryan, Vahagn, Dicken, Yosef, Povodovski, Lital, Rockah, Liat, Bar, Tzlil, Gabay, Matan, Elinger, Dalia, Segal, Ella, Haimov, Ora, Antoshvili, Maya, Drori, Anat London, Poulsen, Tanoya, Herman, Asael, Emmanuel, Rafi, Dale, David C. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9240714/ https://www.ncbi.nlm.nih.gov/pubmed/35795780 http://dx.doi.org/10.1016/j.omtm.2022.06.002 |
Ejemplares similares
-
Comparison of Gene Editing versus a Neutrophil Elastase Inhibitor as Potential Therapies for ELANE Neutropenia
por: Makaryan, Vahagn, et al.
Publicado: (2022) -
CRISPR/Cas9-mediated ELANE knockout enables neutrophilic maturation of primary hematopoietic stem and progenitor cells and induced pluripotent stem cells of severe congenital neutropenia patients
por: Nasri, Masoud, et al.
Publicado: (2020) -
Annual Report of the ELAN Collaboration
por: Richard, F, et al.
Publicado: (2005) -
Annual Report of the ELAN Collaboration
por: Richard, F, et al.
Publicado: (2006) -
Annual Report of the ELAN Collaboration
por: Richard, F, et al.
Publicado: (2007)